Scout | RFA-TR-23-017: Miniaturization and Automation of Tissue Chip Systems (MATChS) (U43/U44 Clinical Trial Not Allowed)

grant

Miniaturization and Automation of Tissue Chip Systems (MATChS) (U43/U44 Clinical Trial Not Allowed)

RFA-TR-23-017

Summary

This grant opportunity supports small businesses in developing MATChS through a cooperative agreement. Projects should focus on creating tools and technologies for high-throughput automated processes that include on-line sensing, rapid data acquisition, and analysis to minimize manual work. Successful projects will lead to more widely available miniaturized automated tissue chip platforms that…

This Notice of Funding Opportunity (NOFO) invites eligible United States small business concerns (SBCs) to submit Small Business Innovation Research (SBIR) Phase I, Phase II, Fast-Track and Direct to Phase II grant applications. The funding opportunity will utilize a U43/U44 cooperative agreemen…

Source

Agency: Department of Health and Human Services

Sub-agency: National Institutes of Health

Phase II

Phase I

Awards & funding

Award Floor: $350,000

Eligibility

For-Profit Organizations: United States Small Business Concerns (SBCs) meeting SBA SBIR eligibility (organized for profit; place of business in the U.S.; operates primarily in the U.S. or makes a significant contribution to the U.S. economy; ≤500 employees including affiliates)

For-Profit Organizations: Joint ventures that qualify as SBCs under SBA rules (SBIR-eligible; with <50% participation by foreign business entities in the joint venture)

For-Profit Organizations: SBCs majority-owned by multiple venture capital operating companies, hedge funds, or private equity firms (SBIR-only; not eligible for STTR)

Core eligibility

Only United States Small Business Concerns (SBCs) are eligible to apply under this NOFO, which uses the SBIR cooperative agreement mechanism.
SBA SBIR/STTR definition applies. An SBC must: • Be organized for profit with a place of business located in the Un…

Dates

Opportunity Released: November 21, 2023

Open for Submission: November 21, 2023

Submission Deadline: February 23, 2026

Application Window Closes: February 23, 2026

Supporting links